Heart fatty-acid-binding protein (H-FABP) is a promising early marker for detecting acute myocardial infarction, appearing in blood as early as 1.5 hours after symptom onset.
Does heart fatty-acid-binding protein (H-FABP) have clinical value as a marker of myocyte necrosis in acute coronary syndromes?
H-FABP is a promising early biomarker for acute myocardial infarction, appearing in the blood within 1.5 hours of symptom onset.
Heart fatty-acid-binding protein (FABP) is a small cytosolic protein that is abundant in the heart and has low concentrations in the blood and in tissues outside the heart. It appears in the blood as early as 1.5 h after onset of symptoms of infarction, peaks around 6 h and returns to baseline values in 24 h. These features of H-FABP make it an excellent potential candidate for the detection of acute myocardial infarction (AMI). We review the strengths and weaknesses of H-FABP as a clinically applicable marker of myocyte necrosis in the context of acute coronary syndromes.
Al-Hadi et al. (Wed,) conducted a review in Acute myocardial infarction / acute coronary syndromes. Heart fatty-acid-binding protein (H-FABP) was evaluated. Heart fatty-acid-binding protein (H-FABP) is a promising early marker for detecting acute myocardial infarction, appearing in blood as early as 1.5 hours after symptom onset.